BUSINESS
JM Financial Q1 net profit up 12% at Rs 142.7cr
Revenue of the company rose 23 percent at Rs 827.7 crore versus Rs 673.2 crore.
BUSINESS
Lupin Q1 PAT may dip 2.9% YoY to Rs. 347.5 cr: Kotak
Net Sales are expected to increase by 6.1 percent Y-o-Y (up 1.7 percent Q-o-Q) to Rs. 4,104.2 crore, according to Kotak.
BUSINESS
Bajaj Finance likely to report strong earnings in Q1; key things to watch out for
Kotak expects the NBFC to report loan growth of 35 percent, which along with a stable NIM, will push NII up 36 percent.
BUSINESS
Laurus Labs Q1 PAT may dip 19.6% YoY to Rs. 31.3 cr: Kotak
Net Sales are expected to increase by 2.5 percent Y-o-Y (down 10.1 percent Q-o-Q) to Rs. 503.6 crore, according to Kotak.
BUSINESS
ONGC shares jump over 5% on reports board approves stake sale in Pawan Hans
Oil and Natural Gas Corporation (ONGC) wants its interest to be clubbed with the 51 percent government stake that is already on offer for sale.
BUSINESS
Idea falls 8% on report that co, Voda may pay Rs 7,200-cr spectrum dues to DoT to avoid merger delay
Idea and Vodafone are likely to pay Rs 7,268 crore spectrum dues to the department of telecommunication (DoT) ‘under protest’ in a few weeks, sources told CNBC-TV18.
BUSINESS
Buy Thirumalai Chemicals, target Rs 1,945: Mazhar Mohammad
BUSINESS
HCG Q1 PAT may dip 85.8% YoY to Rs. 7 cr: Kotak
Net Sales are expected to increase by 20.5 percent Y-o-Y (up 3.6 percent Q-o-Q) to Rs. 230.3 crore, according to Kotak.
BUSINESS
Hold V2Retail with a target of Rs 342: Mazhar Mohammad
In case if it closes above Rs 425 then a fresh buying should be considered for a target of Rs 490 whereas a breakdown below Rs 380 on a closing basis.
TRENDS
Cutting role of docs: Americans may soon get prescription drugs via mobile apps
The objective behind the proposed move is to cut down healthcare costs, said the FDA
TECHNOLOGY
Hydrogen-powered Hyundai Nexo to launch in the UK in early 2019
The Nexo claims a 0-62 mph time of 9.2 seconds although since it is an electric motor, every ounce of torque is delivered right from standstill.
BUSINESS
Exit Trent on rallies, says Mazhar Mohammad
After witnessing correction last week from the higher end of the range, it looks prudent to exit this counter on rallies around Rs 350 levels and re-enter only on a breakout above 365 on a closing basis.
BUSINESS
Buy JBM Auto, with target of Rs 409, says Mazhar Mohammad
Long-term investors can buy into this counter with a stop below Rs 305 on a closing basis.
POLITICS
Delhi government to build 10,000 classrooms by end of 2019: Dy CM Manish Sisodia
Delhi cabinet sanctioned construction of 12,748 rooms in government schools, which will include 9,981 classrooms, 106 multipurpose halls, 328 laboratories and 204 libraries
BUSINESS
UltraTech Cement Q1 profit falls 33% to Rs 598 cr, board approves Century Cement demerger
Key concerns highlighted by the company in its filing are rising cost pressures, likely increase in interest rates and sluggish demand in the Tier-II and III urban housing and commercial segment.
BUSINESS
Hold Venkys, but exit on rallies towards Rs 2,700: Mazhar Mohammad
Investors can hold the stock with a stop below Rs 2,120 on a closing basis and exit on rallies towards Rs 2,700.
BUSINESS
Buy Divis Laboratories with a target of Rs 1220: Hadrien Mendonca
The projections of the breakout indicate stock has the potential of rallying towards its potential target of Rs 1220 levels in the medium term.
BUSINESS
Buy Axis Bank, target Rs 580, says Aditya Agarwala
The stock can be bought in the range of Rs 535 -540 for targets of Rs 565-580, and keep a stop loss placed below Rs 519.
BUSINESS
Buy V-Guard with a target of Rs 216: Aditya Agarwala
On the weekly chart, it has taken support at the 127% Fibonacci extension level. A sustained trade above Rs 196 will extend the rise to levels of 207- 216.
BUSINESS
Closing Bell: Sensex ends almost 150 pts lower, Nifty below 11,000; midcaps crack
The Sensex ended lower by 146.52 points or 0.40% at 36373.44, while the Nifty was down 26.00 points or 0.24% at 10982.00.
BUSINESS
Buy Titan Company, target Rs 930: Aditya Agarwala
The stock can be bought in the range of Rs 840-850 for targets of Rs 900-930, keeping a stop loss placed below Rs 800.
BUSINESS
Dr Reddy’s Laboratories Q1 PAT seen up 421.7% YoY to Rs. 308.3 cr: Kotak
Net Sales are expected to increase by 9.7 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 3,638.8 crore, according to Kotak.
BUSINESS
Dr Lal Pathlabs Q1 PAT seen up 13.3% YoY to Rs. 50.1 cr: Kotak
Net Sales are expected to increase by 16 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 289.2 crore, according to Kotak.
BUSINESS
Bajaj Finance shares up 2% to hit record high ahead of June quarter earnings
KR Choksey expects Bajaj Finance's AUM to grow 35 percent YoY, owing to the company's dominant position in the consumer finance segment.
